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Abstract An efficient and straightforward semisynthesis of the antiprotozoal 
abietane diterpenoid (−-)-sugikurojin A, starting from the readily available 
methyl ester of callitrisic acid (4-epidehydroabietic acid) isolated from 
sandarac resin, is reported. This optimized semisynthetic route provides a 
convenient source of the antiprotozoal compound in four steps with 50% 
overall yield from methyl callitrisate for further biological studies. 
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Aromatic abietane diterpenoids are well-known natural 
products found in the plant kingdom, which have shown a wide 
range of biological activities.1 Their synthetic derivatives have 
been extensively studied as potential chemotherapeutics.2 In 
recent years, an interesting subgroup of abietanes bearing an 
unusual oxygenated group at the axial C-19 position, rather than 
the equatorial C-18 position, have been isolated and subjected 
to biological studies. For example, sugikurojin A (1) (Figure 1) 
was isolated from the Japanese cedar Cryptomeria japonica, 
which is called “sugi” in Japanese.3 The synthetic levorotatory 
enantiomer of this phenolic diterpenoid has shown significant 
antileishmanial and trypanocidal activities.4 The isolation of 
jiadifenoic acids C (2) and B (3) (Figure 1) and related 
metabolites has led to some biological studies aimed at their 
antiviral properties.5 Other examples of bioactive C19-
functionalized abietanes are the anti-inflammatory6 majusanic 
acid B (4) and the cytotoxic7  and immunosuppressive8  19-
hydroxyferruginol (5) (Figure 1). 
Recently, we reported the semisynthesis of jiadifenoic acid C (2) 
from the methyl ester (6) of callitrisic acid (4-epidehydroabietic 
acid) isolated from Moroccan sandarac resin.9 Within this work, 
a new protocol for the isolation of methyl callitrisate (6) without 
the use of AgNO3-based chromatography was developed. The 
accessibility to this material prompted further semisynthetic 
studies. Sugikurojin A (1) was considered an interesting 
synthetic target due to the interesting antiparasitic properties 
of the synthetic levorotatory enantiomer and limited access 
from natural sources and synthetic procedures, which require 
lengthy multi-step syntheses. Two semisyntheses of this 
diterpenoid by Alvarez-Manzaneda and co-workers have been 
reported. One route starts from trans-communic acid and the 
other from abietic acid, with thirteen and nineteen steps, 
respectively.10 Both semisyntheses delivered the compound 
with opposite specific rotation to the natural product. These 
lengthy synthetic methods encouraged us to develop a shorter 
semisynthetic route from methyl callitrisate (6), in order to 
provide (−)-sugikurojin A (1) efficiently for further biological 
studies. 
 
Figure 1 Examples of bioactive C19-functionalized abietane diterpenoids. 
In this paper, a straightforward semisynthetic sequence to (−)-
sugikurojin A (1) from the available methyl callitrisate (6), 
which is obtained by esterification of callitrisic acid (4-
epidehydroabietic acid) isolated from Moroccan sandarac resin, 
is reported. 
Methyl callitrisate (6) was selected as starting material for the 
semisynthesis of sugikurojin A (1), since it contains the aromatic 
ring and a C-19 oxygenated function convertible into the target 
molecule. Methyl callitrisate 6 was obtained from Moroccan 
sandarac resin following the reported protocol (Scheme 1).9 
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Scheme 1 Isolation of methyl callitrisate (6) from Sandarac resin. 
With methyl callitrisate (6) in hand, the focus was shifted to the 
synthetic target, compound 1 (sugikurojin A). This aromatic 
diterpenoid shows characteristic structural features such as a 
phenolic group, a double bond between C-6 and C-7, as well as a 
C-19 hydroxymethyl group. Firstly, the introduction of the 
phenolic moiety at C-12 was investigated. A method developed 
recently by Siegel and co-workers, based on arene to phenol 
transformation with phthaloyl peroxide, was firstly studied.11 
This new method had been successfully used with compound 7 
to give phenol 8 in two steps in 63% overall yield (Scheme 2), 
recovering unreacted 7 in 7% yield. When we used these 
conditions with methyl callitrisate 6, a poor yield of phenol 10 
was obtained along with unreacted 6 (19%). Phenol 10 was 
accompanied by regioisomer 11 as a ca. 1:1 (35% yield) 
inseparable mixture as consequence of a non-regioselective 
reaction. 
Another option involves a Friedel-Crafts acylation of the 
aromatic compound followed by Baeyer-Villiger oxidation.12 In 
our group, there was previous experience with this 
methodology, which was used during our synthesis of the 
abietane diterpenoid (+)-ferruginol (9) from phthaloyl-
protected dehydroabietylamine 7 (Scheme 2).13 After some 
optimization changing the amount of solvent, the treatment 
with AcCl (3.5 equiv.) and AlCl3 (3.0 equiv.) of compound 6 in 
1,2-dichloroethane gave the corresponding acetyl derivative 12 
in 76% yield (Scheme 3). Attempts to improve this reaction with 
other conditions used with the C-4 epimer (methyl 
dehydroabietate) of 6 were unsuccessful.14 
Next, the Baeyer-Villiger oxidation of compound 12 with m-
CPBA (2.6 equiv.) and CF3CO2H (1.0 equiv.) in DCM afforded the 
acetate 13 in almost quantitative yield. Thus, the phenolic 
moiety introduction was solved and then it was needed to set up 
the double bond between C-6 and C-7. To this end, benzylic 
oxidation at C-7 followed by reduction and elimination would 
give the required double bond. Standard benzylic oxidation 
conditions with the oxidant CrO3 in HOAc gave ketone 14 in 80% 
yield. This intermediate had 1H and 13C NMR spectra in 
agreement with the reported data, including the specific 
rotation data ([α]D20= +66.0, c 0.8, CHCl3; lit.,10a +53.3, c 0.9, 
CHCl3). The reduction of 14 with excess LiAlH4 in THF at room 
temperature was known to furnish directly the target 
sugikurojin A (1), as a result of acetate, ketone, and methyl ester 
reduction to the corresponding alcohol moieties with 
concomitant benzylic alcohol elimination.10a Initially, we 
suspected that the elimination of the benzylic alcohol 
intermediates, in hands of Alvarez-Manzaneda and co-workers, 
occurred probably after acidic workup.10b However, the reaction 
under similar reduction conditions (LiAlH4 in THF at room 
temperature)10a and both acidic and basic workup protocols 
gave sugikurojin A (1) (ca. 80% yield) as well, without isolation 
of the corresponding benzylic alcohol intermediates. The 1H and 
13C NMR spectra, together with HRMS data (calcd for C20H29O2 
[M+ H]: 301.2168; found: 301.2175) corresponded to those 
reported for the natural product.3 The specific rotation value of 
freshly synthesized sugikurojin A ([α]D25= -35.0, c 0.4, CHCl3) 
was of opposite sign to that reported for the natural compound 
(naturally derived sugikurojin A had [α]D25= +32.8 (c 0.39, 
CHCl3)). It is worthy to mention that synthetic (−)-sugikurojin A 
(1) was quite unstable to air and/or light in a chloroform 
solution prepared for measuring the specific rotation. This 
resulted in evident decomposition by 1H NMR and noticed by the 
yellowing of the solution. Interestingly, a three-day aged sample 





Scheme 2 Attempted introduction of C-12 oxygenation on methyl callitrisate (6). 
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Scheme 3 Semisynthesis of sugikurojin A (1) from methyl callitrisate (6). 
In summary, (−)-sugikurojin A (1), an antiprotozoal agent, was 
synthesized from available methyl ester of callitrisic acid 6 
isolated from sandarac resin, in 50% overall yield. Therefore, the 
synthetic strategy provides an efficient and improved alternative 
to obtain (−)-sugikurojin A (1) for additional studies. Our results 
suggests that the natural sugikurojin A may belong actually to the 
enantiomeric series of that assumed during isolation, unless 
there was either a mistake in the reported sign of the specific 
rotation or the sample decomposed before measuring the same. 
However, to the best of our knowledge, ent-abietanes have not 
been found in Cryptomeria japonica so far. 
 
The experimental section has no title; please leave this line here. 
The melting points were measured with a Büchi 535 apparatus and are 
uncorrected. Optical rotations were measured using a 5 cm cell in a 
Schmidt-Haensch Polartronic-D polarimeter. NMR spectra were recorded 
on a 300 MHz Bruker spectrometer. All spectra were recorded in CDCl3 as 
solvent unless otherwise stated. Complete assignments of 13C NMR 
multiplicities were made on the basis of DEPT experiments. J values are 
given in Hz. MS data were acquired on a QTOF spectrometer. Reactions 
were monitored by TLC using Merck silica gel 60 F-254 in 0.25 mm-thick 
plates. Compounds on TLC plates were detected under UV light at 254 nm 
and visualized by immersion in a 10% sulfuric acid solution and heating 
with a heat gun. Purifications were performed by flash chromatography 
on Merck silica gel (230-400 mesh). Commercial reagent grade solvents 
and chemicals were used as purchased unless otherwise noted. Combined 
organic extracts were washed with brine, dried over anhydrous Na2SO4, 
filtered, and concentrated under reduced pressure. The starting material 
methyl callitrisate (6) was obtained following the reported protocol from 
Moroccan sandarac resin.9 
Methyl 12-acetylabieta-8,11,13-trien-19-oate (12, methyl 12-
acetylcallitrisate).  
To a stirred solution of ester 6 (600 mg, 1.90 mmol) in 1,2-dichloroethane 
(20 mL) at  0 ºC was added AcCl (0.5 mL, 6.7 mmol) followed by AlCl3 (800 
mg, 6.0 mmol) in portions. The mixture was allowed to warm to rt and 
stirred for 24 h. Then, the resulting brown reaction mixture was poured 
into ice-cold aqueous 6N HCl (60 mL) and extracted with Et2O (3 × 20 mL). 
The combined extracts were washed with water (15 mL), and brine (15 
mL), dried, and concentrated. The resulting brown residue was 
chromatographed on silica eluting with n-hexane-EtOAc (9:1) to give 520 
mg (76%) of methyl 12-acetylcallitrisate (12) as a yellowish solid: mp 
124-126 ºC; [α]20D +96 (c 1.0, CHCl3). 
1H NMR (300 MHz) δ  7.41 (1H, s), 7.04 (1H, s), 3.66 (3H, s), 3.46 (1H, m), 
2.54 (3H, s), 1.28 (3H, s), 1.21 (3H, d, J = 6), 1.19 (3H, d, J = 6), 1.03 (3H, s). 
13C NMR (75 MHz) δC 203.3 (s), 177.8 (s), 145.1 (s), 144.8 (s), 139.1 (s), 
136.4 (s), 127.0 (d), 125.7 (d), 52.6 (d), 51.3 (q), 43.9 (s), 39.3 (t), 38.1 (s), 
37.6 (t), 32.0 (t), 30.5 (q), 28.6 (d), 28.5 (q), 24.2 (q), 24.1 (q), 23.0 (q), 
20.8 (t), 19.9 (t). 
HRMS (ESI) m/z 357.2441 [M+ H]+, calcd for C23H33O3: 357.2430. 
Methyl 12-acetoxyabieta-8,11,13-trien-19-oate (13, methyl 12-
acetoxycallitrisate).  
To a stirred solution of methyl ketone 12 (585 mg, 1.64 mmol) in DCM (6 
mL) at 0 ºC were added m-CPBA (1.06 g, 4.3 mmol) and trifluoroacetic 
acid (130 µL, 1.75 mmol) dropwise. The reaction mixture was allowed to 
warm to rt and stirred for 22 h. Then, it was diluted with DCM (10 mL), 
washed with 10% Na2SO3 (10 mL), H2O (10 mL), saturated NaHCO3 (10 
mL), and H2O (10 mL), dried, and concentrated. The resulting oily residue 
was chromatographed on silica eluting with n-hexane-EtOAc (9:1) to give 
600 mg (98%) of acetate 13 as a yellowish solid: mp 126-128 ºC; [α]20D 
+92 (c 0.8, CHCl3). 
1H NMR (300 MHz) δ  6.95 (1H, s), 6.84 (1H, s), 3.65 (3H, s), 2.29 (3H, s), 
1.26 (3H, s),  1.19 (3H, d, J = 6), 1.17 (3H, d, J = 6), 1.01 (3H, s). 
13C NMR (75 MHz) δC 177.8 (s), 169.9 (s), 146.7 (s), 146.3 (s), 137.0 (s), 
133.2 (s), 127.0 (d), 119.1 (d), 52.5 (d), 51.2 (q), 43.9 (s), 39.3 (t), 38.2 (s), 
37.6 (t), 31.6 (t), 28.5 (q), 27.1 (d), 23.0 (q), 22.9 (q), 22.9 (q), 21.0 (t), 20.9 
(q), 19.8 (t). 
HRMS (ESI) m/z 373.2391 [M+ H]+, calcd for C23H33O4: 373.2379. 
Methyl 12-acetoxy-7-oxoabieta-8,11,13-trien-19-oate (14, methyl 
12-acetoxy-7-oxocallitrisate).  
The acetate 13 (927 mg, 2.49 mmol) was dissolved in HOAc (25 mL) and 
cooled to 0-5 ºC before CrO3 (500 mg, 5.0 mmol) was added. The reaction 
mixture was allowed to warm to rt and stirred for 17 h. Then, it was 
diluted with ice-H2O (75 mL) and extracted with diethyl ether (4 × 30 mL). 
The combined organic extracts were washed with H2O (2 × 20 mL), 
saturated NaHCO3 (2 × 30 mL)(carefully, gas evolution) and brine (20 
mL), dried, and concentrated. The resulting residue was 
chromatographed on silica eluting with n-hexane-EtOAc (8:2) to give 768 
mg (80%) of ketone 14 as a yellowish oil that solidified upon standing: mp 
135-137 ºC; [α]20D +66.0 (c 0.8, CHCl3)( lit.,10a +53.3 (c 0.9, CHCl3)). 
1H NMR (300 MHz) δ  8.02 (1H, s), 7.03 (1H, s), 3.70 (3H, s), 3.21 (1H, dd, 
J = 12, 12), 2.98 (2H, m), 2.34 (3H, s), 1.25 (3H, s),  1.23 (3H, d, J = 6), 1.21 
(3H, d, J = 6), 1.11 (3H, s). 
13C NMR (75 MHz) δC 198.1 (s), 177.0 (s), 169.1 (s), 153.4 (s), 152.8 (s), 
138.8 (s), 128.7 (s), 126.2 (d), 118.9 (d), 51.6 (q), 50.1 (d), 43.9 (s), 38.4 
(s), 38.3 (t), 37.5 (t), 37.4 (t), 27.9 (q), 27.3 (d), 22.8 (q), 22.7 (q), 21.3 (q), 
21.0 (q), 19.5 (t). 
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19-hydroxy-6,7-dehydroferruginol (1, sugikurojin A).  
LiAlH4 (142 mg, 3.73 mmol) was added to a stirred solution of 14 (120 
mg, 0.31 mmol) in anhydrous THF (10 mL) at 0 ºC. This mixture was 
allowed to warm to rt and stirred under an argon atmosphere for 16 h. 
After this time, the reaction mixture was quenched by pouring it into ice 
followed by addition of 2 N HCl (6 mL), stirring was continued for 1 h. 
Next, the mixture was extracted with diethyl ether (3 X 20 mL). The 
combined organic layers were washed with brine (10 mL), dried and 
concentrated. The resulting residue was chromatographed on silica 
eluting with diethyl ether to give 78 mg (84%) of 1 as a white solid, after 
concentrating the ether fractions with a bit of n-hexane (otherwise a 
semisolid is obtained): mp 112-114 ºC; [α]25D -35.0 (c 0.4, CHCl3)( lit.,10 -
29.2 (c 0.92, CHCl3)). 
1H NMR (300 MHz) δ  6.89 (1H, s), 6.59 (1H, s), 6.49 (1H, dd, J = 10, 3), 5.97 
(1H, dd, J = 10, 3), 3.86 (1H, d, J = 10), 3.74 (1H, d, J = 10), 3.15 (1H, m), 
2.25 (1H, dd, J = 3, 3), 2.10 (1H, m), 1.88 (1H, m), 1.26 (3H, d, J = 6),  1.23 
(3H, d, J = 6), 1.07 (3H, s), 0.99 (3H, s). 
13C NMR (75 MHz) δC 152.6 (s), 147.0 (s), 131.4 (s), 127.6 (d), 125.8 (d), 
125.7 (s), 124.7 (d), 109.4 (d), 65.9 (t), 50.9 (d), 38.2 (s), 37.4 (s), 35.9 (t), 
35.1 (t), 26.6 (d), 26.0 (q), 22.8 (q), 22.4 (q), 20.7 (q), 18.7 (t). 
HRMS (ESI) m/z 301.2175 [M+ H]+, calcd for C20H29O2: 301.2168. 
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